Search

Displaying results 2531 - 2540 of 9705 in total
  1. Drug

    Crelosidenib

    go.drugbank.com/drugs/DB21642
    Investigational

    Crelosidenib has a monoisotopic molecular weight of 504.28 Da. … Crelosidenib is a small molecule drug.

  2. Drug

    Rosabulin

    go.drugbank.com/drugs/DB20161
    Investigational

    Rosabulin has a monoisotopic molecular weight of 400.1 Da. … Rosabulin is a small molecule drug. Rosabulin is under investigation in clinical trial NCT00276913 (A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors).

  3. Drug

    Lunsotogene parvec

    go.drugbank.com/drugs/DB18278
    ApprovedInvestigational

    It is the first gene therapy to be approved under the Commissioner's National Priority Voucher (CNPV) pilot and represents one of the fastest BLA approvals in modern history, with a time between filing … [L56135,L56136] This landmark decision followed designations as a Regenerative Medicine Advanced Therapy (RMAT) and Fast Track, marking the first-ever gene therapy approved to restore a neurosensory function

  4. Drug

    Bulevirtide

    go.drugbank.com/drugs/DB15248
    ApprovedInvestigational

    [A226305] Bulevirtide, also known as Hepcludex, is a first-in-class entry inhibitor for the treatment of chronic Hepatitis D infection developed by MYR Pharmaceuticals, now part of Gilead. … potentially beneficial synergistic effects in treating chronic Hepatitis D, bulevirtide is also under investigation in clinical trial NCT03852433 (Phase 2b Study of Bulevirtide With [Peginterferon Alfa-2a

  5. Drug

    Aspartyl-alanyl-diketopiperazine

    go.drugbank.com/drugs/DB14940
    Investigational

    Aspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).

  6. Drug

    EU204

    go.drugbank.com/drugs/DB17438
    Investigational

    EU204 (EBViNT) is an Epstein-Barr virus (EBV)-positive T-cell therapy currently undergoing phase 1 and 2a clinical trials in Korea for patients with EBV-positive lymphoma and solid cancer.

  7. Drug

    Elunonavir

    go.drugbank.com/drugs/DB21518
    Experimental

    Elunonavir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Elunonavir is a antiviral. Elunonavir has a monoisotopic molecular weight of 1155.44 Da.

  8. Drug

    Trecadrine

    go.drugbank.com/drugs/DB19785
    Experimental

    Trecadrine is a small molecule drug. The usage of the INN stem '-drine' in the name indicates that Trecadrine is a sympathomimetic. Trecadrine has a monoisotopic molecular weight of 383.22 Da.

  9. Drug

    Droxinavir

    go.drugbank.com/drugs/DB19821
    Experimental

    Droxinavir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Droxinavir is a antiviral. Droxinavir has a monoisotopic molecular weight of 533.39 Da.

  10. Drug

    Flurantel

    go.drugbank.com/drugs/DB19840
    Experimental

    Flurantel is a small molecule drug. The usage of the INN stem '-antel' in the name indicates that Flurantel is a anthelminthic. Flurantel has a monoisotopic molecular weight of 494.05 Da.